Skip to Content

2 Results Found

  • Review
  • Open Access
7 Citations
4,861 Views
19 Pages

14 December 2024

Methotrexate (MTX) is an antifolic agent used in the first line of anti-inflammatory disease treatment and some oncologic issues. The metabolism of MTX is rapid, and the MTX concentration in the blood is not significant 24 h after administration. Unl...

(This article belongs to the Special Issue Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition)
  • Review
  • Open Access
2 Citations
1,498 Views
12 Pages

Low-Dose Methotrexate and Bone Health: Pathophysiological and Clinical Perspectives

  • Anton Sokhan,
  • Judith Haschka,
  • Zora Messner,
  • Jochen Zwerina and
  • Roland Kocijan

6 March 2026

This narrative review summarizes current evidence on the molecular and cellular effects of low-dose methotrexate (LD-MTX) on bone tissue. In addition, it critically examines the limited and heterogeneous data on LD-MTX-associated osteopathy, a rare a...

(This article belongs to the Section Immunology & Rheumatology)